Brand Description
YORVIPATH is the first FDA-approved treatment for hypoparathyroidism in adults, providing continuous exposure to active PTH over 24 hours.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|